NVP AEW 541
Alternative Names: AEW-541; NVP-AEW-541Latest Information Update: 11 Aug 2011
At a glance
- Originator Novartis
- Class Antineoplastics; Pyrimidines; Pyrroles; Small molecules
- Mechanism of Action Insulin-like growth factor I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Haematological malignancies; Solid tumours
Most Recent Events
- 11 Aug 2011 No development reported - Phase-I for Haematological malignancies in USA (PO)
- 11 Aug 2011 No development reported - Phase-I for Solid tumours in USA (PO)
- 24 Oct 2008 Phase-I clinical trials in Haematological malignancies in USA (PO)